Application of expanded noninvasive prenatal test in prenatal diagnosis of fetuses with increased nuchal translucency

References

• Grossman TB, Bodenlos KL, Chasen ST. Abnormal nuchal translucency: residual risk with normal cell-free DNA screening. J Matern Fetal Neonatal Med. 2020;33(18):3062–3067.
   PubMed Web of Science ®Google Scholar
• Miranda J, Paz Y Miño F, Borobio V, et al. Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency. Ultrasound Obstet Gynecol. 2020;55(5):645–651.
   PubMed Web of Science ®Google Scholar
• Srebniak MI, de Wit MC, Diderich KE, et al. Enlarged NT (≥3.5 mm) in the first trimester – not all chromosome aberrations can be detected by NIPT. Mol Cytogenet. 2016;9(1):69.
   PubMedGoogle Scholar
• Sinajon P, Chitayat D, Roifman M, et al. Microarray and RASopathy-disorder testing in fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol. 2020;55(3):383–390.
   PubMed Web of Science ®Google Scholar
• Practice Bulletin No. 162: prenatal diagnostic testing for genetic disorders. Obstet Gynecol. 2016;127(5):e108–e122.
   Web of Science ®Google Scholar
• Ghi T, Sotiriadis A, Calda P, et al. ISUOG Practice Guidelines: invasive procedures for prenatal diagnosis. Ultrasound Obstet Gynecol. 2016;48(2):256–268.
   PubMedGoogle Scholar
• Grati FR, Malvestiti F, Branca L, et al. Chromosomal mosaicism in the fetoplacental unit. Best Pract Res Clin Obstet Gynaecol. 2017;42:39–52.
   PubMed Web of Science ®Google Scholar
• Lund I, Becher N, Christensen R, et al. Prevalence of mosaicism in uncultured chorionic villus samples after chromosomal microarray and clinical outcome in pregnancies affected by confined placental mosaicism. Prenat Diagn. 2020;40(2):244–259.
   PubMed Web of Science ®Google Scholar
• Battaglia P, Baroncini A, Mattarozzi A, et al. Cytogenetic follow-up of chromosomal mosaicism detected in first-trimester prenatal diagnosis. Prenat Diagn. 2014;34(8):739–747.
   PubMed Web of Science ®Google Scholar
• Fan HC, Blumenfeld YJ, Chitkara U, et al. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA. 2008;105(42):16266–16271.
   PubMed Web of Science ®Google Scholar
• Chiu RW, Chan KC, Gao Y, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA. 2008;105(51):20458–20463.
   PubMed Web of Science ®Google Scholar
• Petersen AK, Cheung SW, Smith JL, et al. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory. Am J Obstet Gynecol. 2017;217(6):691.e1–e6.
   PubMed Web of Science ®Google Scholar
• Schwartz S, Kohan M, Pasion R, et al. Clinical experience of laboratory follow-up with noninvasive prenatal testing using cell-free DNA and positive microdeletion results in 349 cases. Prenat Diagn. 2018;38(3):210–218.
   PubMed Web of Science ®Google Scholar
• Liang D, Cram DS, Tan H, et al. Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes. Genet Med. 2019;21(9):1998–2006.
   PubMed Web of Science ®Google Scholar
• Chen S, Lau TK, Zhang C, et al. A method for noninvasive detection of fetal large deletions/duplications by low coverage massively parallel sequencing. Prenat Diagn. 2013;33(6):584–590.
   PubMed Web of Science ®Google Scholar
• Nicolaides KH. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn. 2011;31(1):7–15.
   PubMed Web of Science ®Google Scholar
• Borrell A, Casals E, Fortuny A, et al. First-trimester screening for trisomy 21 combining biochemistry and ultrasound at individually optimal gestational ages: an interventional study. Prenat Diagn. 2004;24(7):541–545.
   PubMed Web of Science ®Google Scholar
• Egloff M, Hervé B, Quibel T, et al. Diagnostic yield of chromosomal microarray analysis in fetuses with isolated increased nuchal translucency: a French multicenter study. Ultrasound Obstet Gynecol. 2018;52(6):715–721.
   PubMed Web of Science ®Google Scholar
• Bakker M, Pajkrt E, Bilardo CM. Increased nuchal translucency with normal karyotype and anomaly scan: what next. Best Pract Res Clin Obstet Gynaecol. 2014;28(3):355–366.
   PubMed Web of Science ®Google Scholar
• Petersen OB, Smith E, Van Opstal D, et al. Nuchal translucency of 3.0–3.4 mm an indication for NIPT or microarray? Cohort analysis and literature review. Acta Obstet Gynecol Scand. 2020;99(6):765–774.
   PubMed Web of Science ®Google Scholar
• Maya I, Yacobson S, Kahana S, et al. Cut-off value of nuchal translucency as indication for chromosomal microarray analysis. Ultrasound Obstet Gynecol. 2017;50(3):332–335.
   PubMed Web of Science ®Google Scholar
• Screening for Fetal Chromosomal Abnormalities: ACOG practice bulletin summary, Number 226. Obstet Gynecol. 2020;136(4):859–867.
   PubMed Web of Science ®Google Scholar
• Lan L, Wu H, She L, et al. Analysis of copy number variation by sequencing in fetuses with nuchal translucency thickening. J Clin Lab Anal. 2020;34(8):e23347.
   PubMed Web of Science ®Google Scholar
• Cotarelo-Pérez C, Oancea-Ionescu R, Asenjo-de-la-Fuente E, et al. A contingent model for cell-free DNA testing to detect fetal aneuploidy after first trimester combined screening. Eur J Obstet Gynecol Reprod Biol X. 2019;1:100002.
   PubMedGoogle Scholar
• Yatsenko SA, Peters DG, Saller DN, et al. Maternal cell-free DNA-based screening for fetal microdeletion and the importance of careful diagnostic follow-up. Genet Med. 2015;17(10):836–838.
   PubMed Web of Science ®Google Scholar
• Jensen TJ, Dzakula Z, Deciu C, et al. Detection of microdeletion 22q11.2 in a fetus by next-generation sequencing of maternal plasma. Clin Chem. 2012;58(7):1148–1151.
   PubMed Web of Science ®Google Scholar
• Zhao C, Tynan J, Ehrich M, et al. Detection of fetal subchromosomal abnormalities by sequencing circulating cell-free DNA from maternal plasma. Clin Chem. 2015;61(4):608–616.
   PubMed Web of Science ®Google Scholar
• Liu H, Gao Y, Hu Z, et al. Performance evaluation of NIPT in detection of chromosomal copy number variants using low-coverage whole-genome sequencing of plasma DNA. PLoS One. 2016;11(7):e0159233.
   PubMed Web of Science ®Google Scholar